Latest news
Loading news…
EsoBiotec
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Medium growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Mont-saint-guibert, Brabant Wallon, Belgium Founded 2020 11-50 employees For Profit
EsoBiotec is a Belgian biotechnology business focused on the discovery of novel cancer therapies.
EsoBiotec was acquired by AstraZeneca in 2025 for $1B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
1
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 12
- Patents granted
- 1
- Trademarks
- 0
- Top patent class
- Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering
- IT spend
- $41K
Company Info
- Founded
- 2020
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 60
- HQ
- Mont-saint-guibert, Brabant Wallon, Belgium
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
- Exit date
- Mar 17, 2025
Signals & Scores
- Heat score
- Medium
- Growth score
- Medium
- Trend (7d)
- -0.5
- Trend (30d)
- -0.6
- Trend (90d)
- -0.2
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to EsoBiotec
Loading news…
FAQs about EsoBiotec
People who checked this page also checked these
Browse the full Acquirezy directory.